Aptima HPV 16 18/45 Genotype Assay
FDA premarket approval P120007/S019 · decided 2019-04-22
Approval details
- PMA number
- P120007
- Supplement
- S019
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Aptima HPV 16 18/45 Genotype Assay
- Generic name
- Kit, rna detection, human papillomavirus
- Applicant
- Gen-Probe Incorporated
- Date received
- 2019-03-01
- Decision date
- 2019-04-22
- Days to decision
- 52 days
- Decision code
- APPR
- Product code
- OYB
- Advisory committee
- Microbiology
- Expedited review
- No
- Location
- San Diego, CA
- Statement
- Approval to revise the release criteria for specificity testing of the Negative QC Panel Internal Control RLU parameter
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| APTIMA TRICHOMONAS VAGINALIS ASSAY (DEN110012) | Gen-Probe Incorporated | 2011-04-19 |